Adaptive Biotechnologies Stock (NASDAQ: ADPT) stock price, news, charts, stock research, profile.
Open | $2.930 |
Close | $3.210 |
Volume / Avg. | 2.000M / 1.473M |
Day Range | 2.930 - 3.335 |
52 Wk Range | 2.605 - 9.080 |
Market Cap | $464.295M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 42 |
Short Interest | 8.13% |
Days to Cover | 5.9 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Adaptive Biotechnologies (NASDAQ: ADPT) through any online brokerage.
Other companies in Adaptive Biotechnologies’s space includes: Harvard Bioscience (NASDAQ:HBIO), Codexis (NASDAQ:CDXS), BioLife Solns (NASDAQ:BLFS), Lifecore Biomedical (NASDAQ:LFCR) and Quanterix (NASDAQ:QTRX).
The latest price target for Adaptive Biotechnologies (NASDAQ: ADPT) was reported by Goldman Sachs on Friday, February 16, 2024. The analyst firm set a price target for 5.00 expecting ADPT to rise to within 12 months (a possible 56.25% upside). 8 analyst firms have reported ratings in the last year.
The stock price for Adaptive Biotechnologies (NASDAQ: ADPT) is $3.2 last updated Today at March 28, 2024 at 5:57 PM EDT.
There are no upcoming dividends for Adaptive Biotechnologies.
Adaptive Biotechnologies’s Q1 earnings are confirmed for Wednesday, May 1, 2024.
There is no upcoming split for Adaptive Biotechnologies.
Adaptive Biotechnologies is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NASDAQ.